img

Global Alzheimer Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Alzheimer Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Alzheimer Drug report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Alzheimer Drug market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Mild Alzheimer and Moderate Alzheimer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Alzheimer Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Alzheimer Drug key companies include Biogen, Eli Lilly and Alzheon, etc. Biogen, Eli Lilly, Alzheon are top 3 players and held % share in total in 2023.
Alzheimer Drug can be divided into Aducanumab, Donepezil, Rivastigmine and Memantine, etc. Aducanumab is the mainstream product in the market, accounting for % share globally in 2023.
Alzheimer Drug is widely used in various fields, such as Mild Alzheimer, Moderate Alzheimer and Severe Alzheimer,, etc. Mild Alzheimer provides greatest supports to the Alzheimer Drug industry development. In 2023, global % share of Alzheimer Drug went into Mild Alzheimer filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Alzheimer Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Biogen
Eli Lilly
Alzheon
Segment by Type
Aducanumab
Donepezil
Rivastigmine
Memantine
Others

Segment by Application


Mild Alzheimer
Moderate Alzheimer
Severe Alzheimer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Alzheimer Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Alzheimer Drug introduction, etc. Alzheimer Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Alzheimer Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.

Table of Content

1 Market Overview of Alzheimer Drug
1.1 Alzheimer Drug Market Overview
1.1.1 Alzheimer Drug Product Scope
1.1.2 Alzheimer Drug Market Status and Outlook
1.2 Global Alzheimer Drug Market Size Overview by Region 2018 VS 2023 VS 2033
1.3 Global Alzheimer Drug Market Size by Region (2018-2033)
1.4 Global Alzheimer Drug Historic Market Size by Region (2018-2023)
1.5 Global Alzheimer Drug Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Alzheimer Drug Market Size (2018-2033)
1.6.1 North America Alzheimer Drug Market Size (2018-2033)
1.6.2 Europe Alzheimer Drug Market Size (2018-2033)
1.6.3 Asia-Pacific Alzheimer Drug Market Size (2018-2033)
1.6.4 Latin America Alzheimer Drug Market Size (2018-2033)
1.6.5 Middle East & Africa Alzheimer Drug Market Size (2018-2033)
2 Alzheimer Drug Market by Type
2.1 Introduction
2.1.1 Aducanumab
2.1.2 Donepezil
2.1.3 Rivastigmine
2.1.4 Memantine
2.1.5 Others
2.2 Global Alzheimer Drug Market Size by Type: 2018 VS 2023 VS 2033
2.2.1 Global Alzheimer Drug Historic Market Size by Type (2018-2023)
2.2.2 Global Alzheimer Drug Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Alzheimer Drug Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Alzheimer Drug Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Alzheimer Drug Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Alzheimer Drug Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Alzheimer Drug Revenue Breakdown by Type (2018-2033)
3 Alzheimer Drug Market Overview by Application
3.1 Introduction
3.1.1 Mild Alzheimer
3.1.2 Moderate Alzheimer
3.1.3 Severe Alzheimer
3.2 Global Alzheimer Drug Market Size by Application: 2018 VS 2023 VS 2033
3.2.1 Global Alzheimer Drug Historic Market Size by Application (2018-2023)
3.2.2 Global Alzheimer Drug Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Alzheimer Drug Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Alzheimer Drug Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Alzheimer Drug Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Alzheimer Drug Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Alzheimer Drug Revenue Breakdown by Application (2018-2033)
4 Alzheimer Drug Competition Analysis by Players
4.1 Global Alzheimer Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer Drug as of 2023)
4.3 Date of Key Players Enter into Alzheimer Drug Market
4.4 Global Top Players Alzheimer Drug Headquarters and Area Served
4.5 Key Players Alzheimer Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Alzheimer Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biogen
5.1.1 Biogen Profile
5.1.2 Biogen Main Business
5.1.3 Biogen Alzheimer Drug Products, Services and Solutions
5.1.4 Biogen Alzheimer Drug Revenue (US$ Million) & (2018-2023)
5.1.5 Biogen Recent Developments
5.2 Eli Lilly
5.2.1 Eli Lilly Profile
5.2.2 Eli Lilly Main Business
5.2.3 Eli Lilly Alzheimer Drug Products, Services and Solutions
5.2.4 Eli Lilly Alzheimer Drug Revenue (US$ Million) & (2018-2023)
5.2.5 Eli Lilly Recent Developments
5.3 Alzheon
5.3.1 Alzheon Profile
5.3.2 Alzheon Main Business
5.3.3 Alzheon Alzheimer Drug Products, Services and Solutions
5.3.4 Alzheon Alzheimer Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Recent Developments
6 North America
6.1 North America Alzheimer Drug Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Alzheimer Drug Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer Drug Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Alzheimer Drug Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer Drug Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Alzheimer Drug Market Dynamics
11.1 Alzheimer Drug Industry Trends
11.2 Alzheimer Drug Market Drivers
11.3 Alzheimer Drug Market Challenges
11.4 Alzheimer Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Alzheimer Drug Market Size (US$ Million) Comparison by Region 2018 VS 2023 VS 2033
Table 2. Global Alzheimer Drug Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Alzheimer Drug Market Size Share by Region (2018-2023)
Table 4. Global Alzheimer Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Alzheimer Drug Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Alzheimer Drug Market Size (US$ Million) by Type: 2018 VS 2023 VS 2033
Table 7. Global Alzheimer Drug Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Alzheimer Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Alzheimer Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Alzheimer Drug Revenue Market Share by Type (2024-2033)
Table 11. North America Alzheimer Drug Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Alzheimer Drug Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Alzheimer Drug Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Alzheimer Drug Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Alzheimer Drug Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Alzheimer Drug Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Alzheimer Drug Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Alzheimer Drug Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Alzheimer Drug Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Alzheimer Drug Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Alzheimer Drug Market Size (US$ Million) by Application: 2018 VS 2023 VS 2033
Table 22. Global Alzheimer Drug Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Alzheimer Drug Revenue Market Share by Application (2018-2023)
Table 24. Global Alzheimer Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Alzheimer Drug Revenue Market Share by Application (2024-2033)
Table 26. North America Alzheimer Drug Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Alzheimer Drug Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Alzheimer Drug Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Alzheimer Drug Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Alzheimer Drug Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Alzheimer Drug Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Alzheimer Drug Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Alzheimer Drug Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Alzheimer Drug Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Alzheimer Drug Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Alzheimer Drug Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Alzheimer Drug Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer Drug as of 2023)
Table 39. Date of Key Players Enter into Alzheimer Drug Market
Table 40. Global Alzheimer Drug Key Players Headquarters and Area Served
Table 41. Alzheimer Drug Product Solution and Service
Table 42. Global Alzheimer Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Biogen Basic Information List
Table 45. Biogen Description and Business Overview
Table 46. Biogen Alzheimer Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Alzheimer Drug Business of Biogen (2018-2023)
Table 48. Biogen Recent Developments
Table 49. Eli Lilly Basic Information List
Table 50. Eli Lilly Description and Business Overview
Table 51. Eli Lilly Alzheimer Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Alzheimer Drug Business of Eli Lilly (2018-2023)
Table 53. Eli Lilly Recent Developments
Table 54. Alzheon Basic Information List
Table 55. Alzheon Description and Business Overview
Table 56. Alzheon Alzheimer Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Alzheimer Drug Business of Alzheon (2018-2023)
Table 58. Alzheon Recent Developments
Table 59. North America Alzheimer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 60. North America Alzheimer Drug Market Size by Country (2024-2033) & (US$ Million)
Table 61. Europe Alzheimer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 62. Europe Alzheimer Drug Market Size by Country (2024-2033) & (US$ Million)
Table 63. Asia-Pacific Alzheimer Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 64. Asia-Pacific Alzheimer Drug Market Size by Region (2018-2023) & (US$ Million)
Table 65. Asia-Pacific Alzheimer Drug Market Size by Region (2024-2033) & (US$ Million)
Table 66. Asia-Pacific Alzheimer Drug Market Share by Region (2018-2023)
Table 67. Asia-Pacific Alzheimer Drug Market Share by Region (2024-2033)
Table 68. Latin America Alzheimer Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 69. Latin America Alzheimer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 70. Latin America Alzheimer Drug Market Size by Country (2024-2033) & (US$ Million)
Table 71. Middle East & Africa Alzheimer Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 72. Middle East & Africa Alzheimer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 73. Middle East & Africa Alzheimer Drug Market Size by Country (2024-2033) & (US$ Million)
Table 74. Alzheimer Drug Market Trends
Table 75. Alzheimer Drug Market Drivers
Table 76. Alzheimer Drug Market Challenges
Table 77. Alzheimer Drug Market Restraints
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer Drug Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Alzheimer Drug Market Size (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Alzheimer Drug Market Share by Regions: 2023 VS 2033
Figure 4. Global Alzheimer Drug Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Alzheimer Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Alzheimer Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Alzheimer Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Alzheimer Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Alzheimer Drug Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Aducanumab
Figure 11. Global Aducanumab Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Donepezil
Figure 13. Global Donepezil Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Rivastigmine
Figure 15. Global Rivastigmine Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Memantine
Figure 17. Global Memantine Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Global Alzheimer Drug Market Size Share by Type: 2023 & 2033
Figure 21. North America Alzheimer Drug Revenue Market Share by Type (2018-2033)
Figure 22. Europe Alzheimer Drug Revenue Market Share by Type (2018-2033)
Figure 23. Asia-Pacific Alzheimer Drug Revenue Market Share by Type (2018-2033)
Figure 24. Latin America Alzheimer Drug Revenue Market Share by Type (2018-2033)
Figure 25. Middle East and Africa Alzheimer Drug Revenue Market Share by Type (2018-2033)
Figure 26. Mild Alzheimer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Moderate Alzheimer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Severe Alzheimer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 29. Global Alzheimer Drug Market Size Share by Application: 2023 & 2033
Figure 30. North America Alzheimer Drug Revenue Market Share by Application (2018-2033)
Figure 31. Europe Alzheimer Drug Revenue Market Share by Application (2018-2033)
Figure 32. Asia-Pacific Alzheimer Drug Revenue Market Share by Application (2018-2033)
Figure 33. Latin America Alzheimer Drug Revenue Market Share by Application (2018-2033)
Figure 34. Middle East and Africa Alzheimer Drug Revenue Market Share by Application (2018-2033)
Figure 35. Alzheimer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2023
Figure 36. Global Top 5 and Top 10 Players Alzheimer Drug Market Share in 2023
Figure 37. North America Alzheimer Drug Market Share by Country (2018-2033)
Figure 38. U.S. Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 39. Canada Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 40. Germany Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 41. France Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 42. U.K. Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 43. Italy Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 44. Russia Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 45. Nordic Countries Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 46. Asia-Pacific Alzheimer Drug Market Share by Region (2018-2033)
Figure 47. China Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 48. Japan Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 49. South Korea Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 51. India Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 52. Australia Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 53. Latin America Alzheimer Drug Market Share by Country (2018-2033)
Figure 54. Mexico Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 55. Brazil Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 56. Middle East & Africa Alzheimer Drug Market Share by Country (2018-2033)
Figure 57. Turkey Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 59. UAE Alzheimer Drug Market Size (2018-2033) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries